Hauptseite > Publikationsdatenbank > Flare phenomenon in O-(2-[ 18 F]-Fluoroethyl)-L-Tyrosine PET after resection of gliomas > print |
001 | 872736 | ||
005 | 20220930130227.0 | ||
024 | 7 | _ | |a 10.2967/jnumed.119.238568 |2 doi |
024 | 7 | _ | |a 0022-3123 |2 ISSN |
024 | 7 | _ | |a 0097-9058 |2 ISSN |
024 | 7 | _ | |a 0161-5505 |2 ISSN |
024 | 7 | _ | |a 1535-5667 |2 ISSN |
024 | 7 | _ | |a 2159-662X |2 ISSN |
024 | 7 | _ | |a 2128/25658 |2 Handle |
024 | 7 | _ | |a pmid:32005771 |2 pmid |
024 | 7 | _ | |a WOS:000568832100013 |2 WOS |
037 | _ | _ | |a FZJ-2020-00214 |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Filss, Christian P |0 P:(DE-Juel1)141877 |b 0 |u fzj |
245 | _ | _ | |a Flare phenomenon in O-(2-[ 18 F]-Fluoroethyl)-L-Tyrosine PET after resection of gliomas |
260 | _ | _ | |a New York, NY |c 2020 |b Soc. |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1599843339_3342 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a PET using O-(2-[18F]Fluoroethyl)-L-tyrosine (18F-FET) is useful to detect residual tumor tissue after glioma resection. Recent animal experiments detected reactive changes of 18F-FET uptake at the rim of the resection cavity within the first two weeks after resection of gliomas. In the present study, we evaluated pre- and postoperative 18F-FET PET scans of glioma patients with particular emphasis on the identification of reactive changes after surgery. Methods: Forty-three patients with cerebral gliomas (9 low-grade, 34 high-grade; 9 primary tumors, 34 recurrent tumors) who had preoperative (time before surgery, median 23 d, range 6-44 d) and postoperative 18F-FET-PET (time after surgery, median 14, range 5–28 d) were included. PET scans (20-40 min p.i.) were evaluated visually for complete or incomplete resection (CR, IR) and compared with MRI. Changes of 18F-FET-uptake in residual tumor were evaluated by tumor-to-brain ratios (TBRmax) and in the vicinity of the resection cavity by maximum lesion-to-brain ratios (LBRmax). Results: Visual analysis of 18F-FET PET scans revealed CR in 16/43 patients and IR in the remaining patients. PET results were concordant with MRI in 69% of the patients. LBRmax of 18F-FET uptake in the vicinity of the resection cavity was significantly higher compared with preoperative values (1.59 ± 0.36 versus 1.14 ± 0.17; n = 43, p<0.001). In 11 patients (26%) a “flare phenomenon” was observed with a considerable increase of 18F-FET uptake compared with preoperative values in either the residual tumor (n = 5) or in areas remote from tumor in the preoperative PET scan (n = 6) (2.92 ± 1.24 versus 1.62 ± 0.75; p<0.001). Further follow-up in five patients showed decreasing 18F-FET uptake in the flare areas in four and progress in one case. Conclusion: Our study confirms that 18F-FET PET provides valuable information for assessing the success of glioma resection. Postoperative reactive changes at the rim of the resection cavity appear to be mild. However, in 23 % of the patients, a postoperative “flare phenomenon” was observed that warrants further investigation. |
536 | _ | _ | |a 572 - (Dys-)function and Plasticity (POF3-572) |0 G:(DE-HGF)POF3-572 |c POF3-572 |f POF III |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef |
700 | 1 | _ | |a Schmitz, Ann k |0 P:(DE-HGF)0 |b 1 |
700 | 1 | _ | |a Stoffels, Gabriele |0 P:(DE-Juel1)131627 |b 2 |u fzj |
700 | 1 | _ | |a Stegmayr, Carina |0 P:(DE-Juel1)156479 |b 3 |u fzj |
700 | 1 | _ | |a Lohmann, Philipp |0 P:(DE-Juel1)145110 |b 4 |u fzj |
700 | 1 | _ | |a Werner, Jan Michael |0 P:(DE-HGF)0 |b 5 |
700 | 1 | _ | |a Sabel, Michael |0 P:(DE-Juel1)165921 |b 6 |
700 | 1 | _ | |a Rapp, Marion |0 P:(DE-HGF)0 |b 7 |
700 | 1 | _ | |a Goldbrunner, Roland |0 P:(DE-HGF)0 |b 8 |
700 | 1 | _ | |a Neumaier, Bernd |0 P:(DE-Juel1)166419 |b 9 |u fzj |
700 | 1 | _ | |a Mottaghy, Felix M. |0 P:(DE-Juel1)132318 |b 10 |u fzj |
700 | 1 | _ | |a Shah, N. Jon |0 P:(DE-Juel1)131794 |b 11 |u fzj |
700 | 1 | _ | |a Fink, Gereon R |0 P:(DE-Juel1)131720 |b 12 |u fzj |
700 | 1 | _ | |a Galldiks, Norbert |0 P:(DE-Juel1)143792 |b 13 |u fzj |
700 | 1 | _ | |a Langen, Karl Josef |0 P:(DE-Juel1)131777 |b 14 |e Corresponding author |u fzj |
773 | _ | _ | |a 10.2967/jnumed.119.238568 |g p. jnumed.119.238568 - |0 PERI:(DE-600)2040222-3 |n 9 |p 1294-1299 |t Journal of nuclear medicine |v 61 |y 2020 |x 0022-3123 |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/872736/files/Filss_2020_Post%20Print_J%20Nucl_Flare%20phenomenon%20in%20O-%282-%5B18F%5D-Fluoroethyl%29-L-Tyrosine%20PET%20after%20resection%20of%20gliomas.pdf |y OpenAccess |
909 | C | O | |o oai:juser.fz-juelich.de:872736 |p openaire |p open_access |p OpenAPC |p driver |p VDB |p openCost |p dnbdelivery |
910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 0 |6 P:(DE-Juel1)141877 |
910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 2 |6 P:(DE-Juel1)131627 |
910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 3 |6 P:(DE-Juel1)156479 |
910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 4 |6 P:(DE-Juel1)145110 |
910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 9 |6 P:(DE-Juel1)166419 |
910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 10 |6 P:(DE-Juel1)132318 |
910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 11 |6 P:(DE-Juel1)131794 |
910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 12 |6 P:(DE-Juel1)131720 |
910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 13 |6 P:(DE-Juel1)143792 |
910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 14 |6 P:(DE-Juel1)131777 |
913 | 1 | _ | |a DE-HGF |b Key Technologies |l Decoding the Human Brain |1 G:(DE-HGF)POF3-570 |0 G:(DE-HGF)POF3-572 |2 G:(DE-HGF)POF3-500 |v (Dys-)function and Plasticity |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |
914 | 1 | _ | |y 2020 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J NUCL MED : 2017 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b J NUCL MED : 2017 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
920 | _ | _ | |l yes |
920 | 1 | _ | |0 I:(DE-Juel1)INM-4-20090406 |k INM-4 |l Physik der Medizinischen Bildgebung |x 0 |
920 | 1 | _ | |0 I:(DE-Juel1)INM-3-20090406 |k INM-3 |l Kognitive Neurowissenschaften |x 1 |
920 | 1 | _ | |0 I:(DE-Juel1)INM-5-20090406 |k INM-5 |l Nuklearchemie |x 2 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a I:(DE-Juel1)INM-4-20090406 |
980 | _ | _ | |a I:(DE-Juel1)INM-3-20090406 |
980 | _ | _ | |a I:(DE-Juel1)INM-5-20090406 |
980 | _ | _ | |a APC |
980 | 1 | _ | |a APC |
980 | 1 | _ | |a FullTexts |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|